Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection
暂无分享,去创建一个
H. Matsuda | E. Imabayashi | Y. Toshimitsu | M. Aikawa | I. Koyama | K. Okamoto | M. Miyazawa | K. Okada
[1] Y. Nishimura,et al. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. , 2010, International journal of radiation oncology, biology, physics.
[2] G. Storme,et al. Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? , 2010, Nuclear medicine communications.
[3] A. Shields,et al. F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer , 2010 .
[4] Y. Nishimura,et al. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. , 2010, International journal of radiation oncology, biology, physics.
[5] T. Hyslop,et al. Does Intraoperative Radiation Therapy Improve Local Tumor Control in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma? A Propensity Score Analysis , 2009, Annals of Surgical Oncology.
[6] Kanji Takahashi,et al. Surgical Results After Preoperative Chemoradiation Therapy for Patients With Pancreatic Cancer , 2009, Pancreas.
[7] E. Hatano,et al. Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. , 2008, Journal of hepato-biliary-pancreatic surgery.
[8] R. Bold,et al. Preoperative evaluation of pancreatic adenocarcinoma. , 2008, Journal of hepato-biliary-pancreatic surgery.
[9] S. Yachida,et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. , 2008, World journal of gastroenterology.
[10] Kanji Takahashi,et al. Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer , 2008, Pancreas.
[11] V. Heinemann,et al. Primary advanced unresectable pancreatic cancer. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[12] K. Hirata,et al. Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial , 2008, Surgery Today.
[13] M. Schwaiger,et al. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Peter Neuhaus,et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.
[15] S. Jinnouchi,et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. , 2006, Journal of hepato-biliary-pancreatic surgery.
[16] V. Heinemann,et al. Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. , 2006, JOP : Journal of the pancreas.
[17] S. Larson,et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. , 2006 .
[18] J. Lee,et al. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] R. Cerfolio,et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. , 2005, The Journal of thoracic and cardiovascular surgery.
[20] W. Oyen,et al. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[21] M. Imamura,et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. , 2004, Surgery.
[22] S. Larson,et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] C. Pinson,et al. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. , 2004, Journal of hepato-biliary-pancreatic surgery.
[24] T. Saga,et al. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] R. Yamada,et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions , 2001, Annals of nuclear medicine.
[26] P. Dupont,et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] N. Tamaki,et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] H. Friess,et al. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. , 1995, Radiology.
[29] H. Friess,et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. , 1995, Gut.